Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced results from the randomized, double-blind, phase 3 ...

A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

Pregnancy is often described as a time of excitement and anticipation, but it also comes with its share of challenges and uncertainties. Most of the time, these challenges are routine—morning sickness ...

Ciara Bolt (Kresge ’24, molecular, cell and developmental biology) transferred to UC Santa Cruz from Cabrillo College in fall 2022, bringing with them a strong foundation that boosted their confidence ...

Objective: Head and neck squamous cell carcinoma (HNSCC) remains a devastating disease with significant morbidity and mortality, despite advances in treatment. HPV-positive HNSCC, in particular, has ...

Cancer detection and screening as a treatment for malignant cells with a biopsy or testing caused by carcinogens and genetics with a cancerous cell as an immunotherapy symbol as a 3D render. Let's ...